Background: Nightmares are extremely dysphoric dreams, which are prevalent and associated with psychological strain. This study investigated (a) the efficacy of an internet-based imagery rehearsal therapy (IRT), (b) the role of imagery rescription, and (c) the role of guidance during internet-based IRT. Methods: A total of 127 patients suffering from mainly idiopathic nightmares were randomly assigned to 1 of 2 IRT internet-based groups (guided IRT; unguided IRT) or to 1 of 2 active control groups (frequency control group; narrative control group). Results: IRT was more effective than a nightmare frequency control condition with respect to nightmare frequency and nightmare distress. Compared to the narrative control group, IRT was only superior in improving nightmare distress but not in nightmare frequency because the narrative control group also improved regarding nightmare frequency. Guidance by a nightmare coach did not affect efficacy, compliance, or dropout. Conclusion: Internet-based IRT seems to be an effective treatment even when offered with minimal guidance by a nightmare coach. Describing the nightmare narrative in detail already decreased nightmare frequency. However, with regard to inducing decreases in nightmare frequency and nightmare distress, IRT was superior to the narrative control group. The results are discussed with reference to the mastery hypothesis.

1.
Swart ML, van Schagen AM, Lancee J, van den Bout J: Prevalence of nightmare disorder in psychiatric outpatients. Psychother Psychosom 2013;82:267-268.
2.
Schredl M: Nightmare frequency and nightmare topics in a representative German sample. Eur Arch Psychiatry Clin Neurosci 2010;260:565-570.
3.
Nadorff MR, Nadorff DK, Germain A: Nightmares: Under-reported, undetected, and therefore untreated. J Clin Sleep Med 2015;11:747-750.
4.
Thünker J, Norpoth M, von Aspern M, Özcan T, Pietrowsky R: Nightmares: knowledge and attitudes in health care providers and nightmare sufferers. J Public Health Epidemiol 2014;6:223-228.
5.
Schredl M, Dehmlow L, Schmitt J: Interest in information about nightmares in patients with sleep disorders. J Clin Sleep Med 2016;12:973-977.
6.
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders (DSM-5). Arlington, American Psychiatric Publishing, 2013.
7.
American Psychological Association: Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Washington, APA, 1994.
8.
Köthe M, Pietrowsky R: Behavioral effects of nightmares and their correlations to personality patterns. Dreaming 2001;11:43-52.
9.
Robert G, Zadra A: Thematic and content analysis of idiopathic nightmares and bad dreams. Sleep 2014;37:409-417.
10.
Levin R, Fireman G: Nightmare prevalence, nightmare distress, and self-reported psychological disturbance. Sleep 2002;25:205-212.
11.
Ohayon MM, Morselli PL, Guilleminault C: Prevalence of nightmares and their relationship to psychopathology and daytime functioning in insomnia subjects. Sleep 1997;20:340-348.
12.
Lancee J, Schrijnemaekers N: The association between nightmares and daily distress. Sleep Biol Rhythms 2013;11:14-19.
13.
Zadra A, Donderi DC: Nightmares and bad dreams: their prevalence and relationship to well-being. J Abnorm Psychol 2000;109:273-281.
14.
Blagrove M, Farmer L, Williams E: The relationship of nightmare frequency and nightmare distress to well-being. J Sleep Res 2004;13:129-136.
15.
Augedal AW, Hansen KS, Kronhaug CR, Harvey AG, Pallesen S: Randomized controlled trials of psychological and pharmacological treatments for nightmares: a meta-analysis. Sleep Med Rev 2013;17:143-152.
16.
Hansen K, Höfling V, Kröner-Borowik T, Stangier U, Steil R: Efficacy of psychological interventions aiming to reduce chronic nightmares: a meta-analysis. Clin Psychol Rev 2013;33:146-155.
17.
Cranston CC, Davis JL, Rhudy JL, Favorite TK: Replication and expansion of “Best Practice Guide for the Treatment of Nightmare Disorder in adults”. J Clin Sleep Med 2011;7:549-553.
18.
Neidhardt EJ, Krakow B, Kellner R, Pathak D: The beneficial effects of one treatment session and recording of nightmares on chronic nightmare sufferers. Sleep 1992;15:470-473.
19.
Thünker J, Pietrowsky R: Effectiveness of a manualized imagery rehearsal therapy for patients suffering from nightmare disorders with and without a comorbidity of depression or PTSD. Behav Res Ther 2012;50:558-564.
20.
Knaevelsrud C, Maercker A: Internet-based treatment for PTSD reduces distress and facilitates the development of a strong therapeutic alliance: a randomized controlled clinical trial. BMC Psychiatry 2007;7:13.
21.
Lange A, van de Ven JP, Schrieken B, Emmelkamp P: Interapie, treatment of posttraumatic stress through the Internet: a controlled trial. J Behav Ther Exp Psychiatry 2001;32:73-90.
22.
Espie CA, Kyle SD, Williams C, Ong JC, Douglas NJ, Hames P, Brown, JSL: A randomized, placebo-controlled trial of online cognitive behavioral therapy for chronic insomnia disorder delivered via an automated media-rich web application. Sleep 2012;35:769-781.
23.
Lancee J, van den Bout J, Sorbi MJ, van Straten A: Motivational support provided via email improves the effectiveness of internet-delivered self-help treatment for insomnia: a randomized trial. Behav Res Ther 2013;51:797-805.
24.
Ritterband LM, Thorndike FP, Gonder-Frederick LA, Magee JC, Bailey ET, Saylor DK, Morin CM: Efficacy of an internet-based behavioral intervention for adults with insomnia. Arch Gen Psychiatry 2009;66:692-698.
25.
Lancee J, Spoormaker VI, van den Bout J: Cognitive behavioral self-help treatment for nightmares: a randomized controlled trial. Psychother Psychosom 2010;79:371-377.
26.
Krakow B, Kellner NR, Neidhardt J, Pathak D, Lambert L: Imagery rehearsal treatment of chronic nightmares: with a thirty month follow-up. J Behav Ther Exp Psychiatry 1993;24:325-330.
27.
Richards D, Richardson T: Computer-based psychological treatments for depression: a systematic review and meta-analysis. Clin Psychol Rev 2012;32:329-342.
28.
Baumeister H, Reichler L, Munzinger M, Lin J: The impact of guidance on Internet-based mental health interventions - a systematic review. Internet Interv 2014;1:205-215.
29.
Lancee J, Spoormaker VI, van den Bout J: Long-term effectiveness of cognitive-behavioural self-help intervention for nightmares. J Sleep Res 2011;20:454-459.
30.
Hautzinger M, Bailer M: Allgemeine Depressions Skala. Manual. Göttingen, Beltz Test, 1993.
31.
Osman A, Bagge CL, Guitierrez PM, Konick LC, Kooper BA, Barrios FX: The Suicidal Behaviors Questionnaire-Revised (SBQ-R): validation with clinical and nonclinical samples. Assessment 2001;5:443-454.
32.
Nijenhuis E, Spinhoven P, Van Dyck R, Van der Hart O, Vanderlinden J: The development of the Somatoform Dissociation Questionnaire (SDQ-5) as a screening instrument for dissociative disorders. Acta Psychiatr Scand 1997;96:311-318.
33.
Lange A, Schrieken B, Blankers M, van de Ven JP, Slot M: Constructie en validatie van de Gewaarwordingenlijst: een hulpmiddelbij het signaleren van een verhoogde kans op psychosen. Direct Ther 2000;20:162-173.
34.
Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M: Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption-II. Addiction 1993;88:791-804.
35.
Wittchen HU, Zaudig M, Fydrich T: Strukturiertes Klinisches Interview für DSM-IV (SKID-I). Göttingen, Hogrefe, 1997.
36.
Böckermann M, Gieselmann A, Sorbi M, Pietrowsky R: Entwicklung einer internetbasierten Selbsthilfe-Intervention zur Bewältigung von Albträumen. Z Psychiatr Psychother Psychosom 2015;63:117-124.
37.
Belicki K: Nightmare frequency versus nightmare distress: relations to psychopathology and cognitive style. J Abnorm Psychol 1992;101:592-597.
38.
Böckermann M, Gieselmann A, Pietrowsky R: What does nightmare distress mean? Factorial structure and psychometric properties of the Nightmare Distress Questionnaire (NDQ). Dreaming 2014;24:279-289.
39.
Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ: The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatr Res 1989;28:193-213.
40.
Spiegelhalder K, Backhaus J, Riemann D: Schlafstörungen. Göttingen, Hogrefe, 2011.
41.
Schmidt J, Lamprecht F, Wittmann WW: Zufriedenheit mit der stationären Versorgung. Entwicklung eines Fragebogens und erste Validitätsuntersuchungen. Psychother Psychosom Med Psychol 1989;39:248-255.
42.
Morris SB: Estimating effect sizes from pretest-posttest-control group designs. Organ Res Methods 2008;11:364-386.
43.
Faul F, Erdfelder E, Lang A-G, Buchner A: G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 2007;39:175-191.
44.
Germain A, Krakow B, Faucher B, Zadra A, Nielsen T, Hollifield M, Warner TD, Koss M: Increased mastery elements associated with imagery rehearsal treatment for nightmares in sexual assault survivors with PTSD. Dreaming 2004;14:195-206.
45.
Krakow B, Hollifield M, Johnston L, Koss M, Schrader R, Warner TD, Tandberg D, Lauriello J, McBride L, Cutchen L, Cheng D, Emmons S, Germain A, Melendrez D, Sandoval D, Prince H: Imagery rehearsal therapy for chronic nightmares in sexual assault survivors with posttraumatic stress disorder: a randomized controlled trial. JAMA 2001;286:537-545.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.